Impact of Pharmaceutical Prior Authorisation Policies
- 1 January 2007
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 25 (8) , 637-648
- https://doi.org/10.2165/00019053-200725080-00002
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Prior Authorization Policies for Selective Cyclooxygenase-2 Inhibitors in MedicaidMedical Care, 2006
- Differential Effect of Early or Late Implementation of Prior Authorization Policies on the Use of Cox II InhibitorsMedical Care, 2006
- When gatekeepers meet the sentinel: the impact of a prior authorization requirement for cefuroxime on the prescribing behaviour of community‐based physiciansBritish Journal of Clinical Pharmacology, 2006
- Medicaid Cost Containment And Access To Prescription DrugsHealth Affairs, 2005
- Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluationsBMJ, 2004
- Pricing and reimbursement of drugs in DenmarkThe European Journal of Health Economics, 2003
- Home hospitalisation of exacerbated chronic obstructive pulmonary disease patientsEuropean Respiratory Journal, 2003
- DiscussionSocial Science & Medicine, 1998
- The sentinel effect in an outpatient managed care setting.Professional Psychology: Research and Practice, 1998
- The doctor as double agent: Information asymmetry, health insurance, and medical careJournal of Health Economics, 1991